Target intelligence / Profile preview

NADH:ubiquinone oxidoreductase subunit A8 (NDUFA8)

Target
NDUFA8
Molecular classification
Enzyme subunit, Mitochondrial electron transport chain component, Accessory subunit of Complex I
01

Overview

NADH:ubiquinone oxidoreductase subunit A8 (NDUFA8) is an **accessory subunit** of mitochondrial Complex I, the first and largest enzyme complex of the electron transport chain. It is **not directly involved in catalysis**, but is essential for structural integrity and proper function of Complex I, which catalyzes electron transfer from NADH to ubiquinone coupled with proton translocation across the mitochondrial inner membrane. This process is crucial for ATP generation by oxidative phosphorylation[5][6][1][4][2]. Defects in Complex I, including its accessory subunits such as NDUFA8, are linked to various mitochondrial diseases and are implicated in some neurodegenerative diseases[1][5].

Other names
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 8Complex I-19kD subunitCI-PGIVPGIVMGC793Complex I PGIV subunitNADH-ubiquinone oxidoreductase 19 kDa subunitMC1DN37
02

Mechanism of action

Inhibition of electron transfer from NADH to ubiquinone at Complex I (i.e., inhibition of NADH:ubiquinone oxidoreductase impairs mitochondrial respiration)

03

Biological functions

Mitochondrial electron transport (NADH to ubiquinone)Cellular energy metabolismOxidative phosphorylation
04

Disease associations

Neurodegenerative diseaseMitochondrial disordersDefects or depletion of Complex I are implicated in disorders affecting energy metabolism and neurodegeneration
05

Safety considerations

Inhibition or malfunction leads to impaired ATP production and increased reactive oxygen speciesPotential for lactic acidosis and neurotoxicity (typically applies to Complex I disruption overall)
06

Interacting drugs

Rotenone (Complex I inhibitor, not specific for NDUFA8 but inhibits the whole complex)

1 more in the full profile.

07

Biomarkers

Decreased Complex I activity in mitochondrial function testing (not specific for NDUFA8, but for complex I defects)

Beyond the preview

Go deeper on NADH:ubiquinone oxidoreductase subunit A8 (NDUFA8).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on NADH:ubiquinone oxidoreductase subunit A8 (NDUFA8).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call